Wednesday, May 05, 2021 1:45:17 PM
The timeline would suggest Bioniz Therapeutics filed for an EOP2 meeting at some point in December 2020 and their meeting happened within 30 days of filing the request. The below example isn't even COVID-19 related, so I'm not sure if the example even falls into an expedited category. Meaning, a COVID-19 related request could possibly be within weeks (1-4) not months (1-2):
DEC 05, 2020, 10:30 ET
Bioniz Announces Positive Clinical Data of BNZ-1, First Anti-Cytokine Therapy to Demonstrate Efficacy in Treating Refractory Cutaneous T-Cell Lymphoma
JAN 04, 2021, 09:00 ET
Bioniz Announces Positive End of Phase 2 Meeting with the FDA for BNZ-1 for the Treatment of Refractory Cutaneous T-Cell Lymphoma
www.prnewswire.com/news/bioniz-therapeutics%2C-inc./
Just a thought,
M$
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM